Browse Related Topics For:

Biotechnology

260
Patents
210
Pharmaceutical Industry
133
Patent Litigation
98
Patent Infringement
79
Life Sciences
77
Patent-Eligible Subject Matter
76
FDA
67
Pharmaceutical Patents
57
DNA
55
SCOTUS
48
USPTO
45
Popular
44
EPA
43
Medical Devices
41
Myriad
40
USDA
35
AMP v Myriad
33
Healthcare
31
ANDA
30
Human Genes
30
Prescription Drugs
25
Mayo v. Prometheus
24
EU
24
OSTP
21
Biofuel
21
Genetic Materials
20
Venture Capital
19
DOE
19
Inter Partes Review (IPR) Proceeding
19
Patent Trial and Appeal Board
18
Biosimilars
18
Generic Drugs
18
Renewable Energy
18
Technology
17
Infringement
17
Myriad-Mayo
17
Public Comment
16
China
16
Innovation
16
Patent Applications
15
America Invents Act
15
Chemicals
15
Patent Reform
15
Toxic Substances Control Act (TSCA)
14
Biologics
14
Novartis
14
Startups
13
CLS Bank v Alice Corp
13
GMO
13
Public Meetings
12
Nanotechnology
11
Biobased Chemicals
11
Bioproducts
11
BRCA
11
Energy Sector
11
Initial Public Offerings
11
Patent Invalidity
11
Pfizer
11
Section 101
11
Sequenom
10
Actavis Inc.
10
Australia
10
Cancer
10
Compliance
10
Genetically Engineered Seed
10
Intellectual Property Protection
10
Manufacturers
10
Monsanto
9
Emerging Growth Companies
9
Entrepreneurs
9
Farms
9
Food Labeling
9
Food Manufacturers
9
Funding
9
GlaxoSmithKline
9
Medical Research
9
Mylan Pharmaceuticals
9
Research and Development
9
Software
8
Copyright
8
Merck
8
Private Equity
8
Transparency
7
Acquisitions
7
Appeals
7
Bowman v Monsanto
7
Claim Construction
7
Diagnostic Method
7
Diagnostic Tests
7
FDA Approval
7
FIFRA
7
Genetic Testing
7
Medicare
7
Mergers
7
Obama Administration
7
Obviousness
7
OMB
7
Personalized Medicine
7
Product of Nature Doctrine
7
Tax Credits
7
Teva Pharmaceuticals
7
Trans-Pacific Partnership
6
Affordable Care Act
6
AstraZeneca
6
Declaratory Judgments
6
Economic Development
6
Emerging Technology Companies
6
En Banc Review
6
Enforcement Actions
6
European Patent Office
6
First-to-File
6
First-to-Invent
6
Foreign Investment
6
Inventions
6
Investors
6
Oil & Gas
6
Proposed Legislation
6
Regulatory Agenda
6
SEC
6
Summary Judgment
6
UK
6
Universities
5
3D Printing
5
AbbVie
5
Apotex
5
Capital Raising
5
Clinical Trials
5
CMS
5
Drug Pricing
5
European Commission
5
European Court of Justice (ECJ)
5
Food Safety
5
Hedge Funds
5
Inventors
5
JOBS Act
5
Licenses
5
Patent Exhaustion
5
Pesticides
5
Petition for Writ of Certiorari
5
Preemption
5
Scientific Research
5
Trade Secrets
5
Venture Funding
4
23andMe
4
Abbott Laboratories
4
Amgen
4
Amicus Briefs
4
Barack Obama
4
Biologics Price Competition and Innovation Act of 2009
4
Biopharmaceutical
4
BPCIA
4
Clean Water Act
4
Corporate Taxes
4
Covered Business Method Patents
4
Digital Health
4
Due Diligence
4
Eli Lilly
4
Expert Testimony
4
Exports
4
Financing
4
Food Supply
4
FSMA
4
FTC
4
Gene Patenting
4
Guidance Update
4
IPO
4
Janssen Pharmaceuticals
4
Legal Perspectives
4
Legislative Agendas
4
Limelight v Akamai
4
Natural Products
4
OECD
4
Par Pharmaceutical
4
Prior Art
4
Professional Conferences
4
Regulatory Standards
4
Renewable Fuel Standard
4
Request For Information
4
Safe Harbors
4
Sandoz
4
Securities Fraud
4
Seeds
4
Stem cells
4
Sunshine Act
4
Tax Incentives
4
Trade Agreements
4
UK Brexit
4
Valuation
3
21st Century Cures Initiative
3
Ambry
3
Anti-Corruption
3
APHIS
3
Ariosa
3
Bayh-Dole Act
3
Bribery
3
Cephalon
3
CERCLA
3
Clean Air Act
3
Corporate Counsel
3
Cuba
3
Defend Trade Secrets Act (DTSA)
3
Direct Infringement
3
Disclosure Requirements
3
Discovery
3
Dismissals
3
E-Commerce
3
Equity Financing
3
European Food Safety Authority (EFSA)
3
European Patent Convention
3
Exemptions
3
False Claims Act (FCA)
3
FCC
3
FDCA
3
Final Rules
3
Genentech
3
Hatch-Waxman
3
Health Care Providers
3
Health Information Technologies
3
Health Insurance
3
Healthcare Reform
3
HHS
3
Hospitals
3
India
3
Innovation Act
3
Insurance Industry
3
Intellectual Property Litigation
3
Inversion
3
IP License
3
Japan
3
Method Claims
3
Misappropriation
3
NIH
3
Noninfringement
3
PATENT Act
3
Patent Prosecution
3
Patent Royalties
3
Patent Term Adjustment
3
Patent Trolls
3
Pending Legislation
3
RCRA
3
Royalties
3
Sanofi-Aventis
3
Sustainability
3
Telecommunications
3
Telemedicine
3
Trade Associations
3
Trade Policy
3
Trademarks
3
Unified Patent Court
3
Unitary Patent
3
Utility Patents
3
Webinars
3
White Collar Crimes
3
Young Lawyers
2
21st Century Cures Act
2
Abstract Ideas
2
Abuse of Process
2
ACLU
2
Additive Manufacturing
2
Advisory Committee
2
Agricultural Land
2
Aircraft
2
Akamai Technologies
2
All Natural
2
Allergan Inc
2
Alzheimer's
2
Antimicrobials
2
Antitrust Litigation
2
Banks
2
Bristol-Myers Squibb
2
Business Taxes
2
Buyouts
2
Capital Formation
2
Celltrion
2
Class Action
2
Climate Change
2
Clinical Laboratories
2
Cloud Computing
2
Comment Period
2
Complete Genomics
2
Country of Origin
2
Criminal Prosecution
2
Cross-Border Transactions
2
Crowdfunding
2
Customs
2
Cybersecurity
2
Data Protection
2
Department of Defense (DOD)
2
Diesel Fuel
2
Dispute Resolution
2
Dow Jones
2
Early Stage Companies
2
Energy Policy
2
Enforcement
2
Environmental Liability
2
Environmental Policies
2
Ethics
2
EU-US Privacy Shield
2
European Medicines Agency (EMA)
2
Farm Workers
2
FCPA
2
Federal Funding
2
Federal Register
2
FFDCA
2
Financial Institutions
2
Forest Laboratories
2
Free Speech
2
General Motors
2
Generic
2
Genetic Technologies Ltd.
2
Gilead Sciences
2
Good Faith
2
Green Chemistry
2
H-1B
2
Hazardous Waste
2
Imports
2
Indefiniteness
2
Induced Infringement
2
Information Reports
2
Injunctions
2
Integra
2
Inter Partes Reexamination
2
Interference Proceeding
2
International Data Transfers
2
IRIS
2
Joinder
2
Jurisdiction
2
Kickstarter
2
Lyft
2
Marketing
2
Means-Plus-Function
2
Medicaid
2
Mexico
2
Misrepresentation
2
Monopolization
2
Motion to Amend
2
Motion to Dismiss
2
NAFTA
2
Nasdaq
2
National Academy of Sciences (NAS)
2
National Cancer Moonshot
2
Nautilus Inc. v. Biosig Instruments
2
New Legislation
2
Office of Chemical Safety & Pollution Prevention (OCSPP)
2
OIG
2
Organic
2
Patent Examinations
2
Patent Ownership
2
Personal Liability
2
Petition For Rehearing
2
PHRMA
2
Physicians
2
Pleading Standards
2
Pleadings
2
Pollinators
2
Post-Grant Review
2
Precision Medicine Initiative (PMI)
2
Prometheus
2
Publicly-Traded Companies
2
Regulatory Oversight
2
Reimbursements
2
Research Funding
2
Reversal
2
Risk Management
2
Sanctions
2
Sandoz v Amgen
2
Settlement
2
Shareholder Activism
2
Small Business
2
SNUR
2
Social Media
2
Software Developers
2
Software Patents
2
South Africa
2
Substance Abuse
2
Surveys
2
Tax Rates
2
Technical Conference
2
Technology Sector
2
The Patent Box
2
Toxic Chemicals
2
Trade Promotion Authority
2
Trump Administration
2
U.S. Commerce Department
2
US-EU Safe Harbor Framework
2
Valeant
2
Waters of the United States
2
Watson Pharmaceuticals
2
Working Groups
2
WTO
1
Accredited Investors
1
Administrative Procedure Act
1
Advanced Notice of Proposed Rulemaking (ANPRM)
1
Advertising
1
Africa
1
Agribusiness
1
AIDS
1
Alice Corporation
1
Amended Regulation
1
American Arbitration Association
1
Angel Investors
1
Animal Patents
1
Animal Testing
1
Anti-Kickback Statute
1
Anticipation
1
Apple
1
Appraisal Awards
1
Appropriation
1
Arbitration
1
Artificial Intelligence
1
Asset Protection
1
Asset Seizure
1
Assignment of Inventions
1
Assignments
1
ASTM
1
Australian Competition and Consumer Commission
1
Australian Patent Office
1
Automotive Industry
1
Bad Faith
1
Ballot Measures
1
Ballots
1
Banking Sector
1
Bayer
1
BEPS
1
Best Efforts Clauses
1
BIA
1
Bilski
1
Bioengineering
1
Biomass
1
Biomass Energy Research
1
BIS
1
Board of Directors
1
Boeing
1
BRACA Genes
1
Brazil
1
Broadest Reasonable Interpretation Standard
1
CAD/CAM Software
1
CAFC
1
Canada
1
Capital Gains
1
Capital Markets
1
Carbon Emissions
1
Certiorari
1
CFDA
1
CFIUS
1
Chamber of Commerce
1
Chemical Compounds
1
Chemical Weapons
1
Chevron Deference
1
Chief Compliance Officers
1
Chilling Effect
1
Chrysler
1
Cisco
1
City of San Jose
1
Clean Tech
1
Clear Error Standard
1
Climate Action Plan
1
Co-payments
1
Coca Cola
1
Colleges
1
Commercial Bankruptcy
1
Commercial Speech
1
Commercially Reasonable Efforts
1
Competitive Bidding
1
Compulsory Licenses
1
Computer Fraud and Abuse Act (CFAA)
1
Confidential Information
1
Construction Disputes
1
Contamination
1
Continuing Legal Education
1
Contract Disputes
1
Copyright Infringement
1
Copyright Office
1
Corporate Integrity Agreement
1
Corporate Misconduct
1
Corporate Officers
1
Corruption
1
Counterclaims
1
Covered Business Method Proceedings
1
Covered Entities
1
Credit Suisse
1
Crops
1
Cuozzo Speed Technologies
1
Cyber Attacks
1
Cybersecurity Information Sharing Act (CISA)
1
Damages
1
Data Collection
1
Data Security
1
Data Use Policies
1
Databases
1
Daubert Standards
1
De Novo Standard of Review
1
De-Risking
1
Department of Agriculture
1
Department of Transportation (DOT)
1
Derivative Suit
1
Deutsche Bank
1
Disgorgement
1
Divided Infringement
1
DOJ
1
DOL
1
Donations
1
Draft Guidance
1
DuPont
1
Economic Espionage Act
1
Educational Institutions
1
Election Results
1
Electricity
1
Electronic Filing
1
Electronic Medical Records
1
Electronic Protected Health Information (ePHI)
1
Electronic Reporting
1
Email
1
Emergency Response
1
Employee Training
1
Endangered Species Act (ESA)
1
Enterprise Zones
1
Entertainment Industry
1
Environmental Violations
1
EPO
1
Ethanol
1
Events
1
Evidence
1
Ex Parte
1
Examiners
1
Exclusive Licenses
1
Exit Strategies
1
Expedited FDA Approval
1
Export Administration Regulations
1
Export Controls
1
False Advertising
1
False Statements
1
Fantasy Sports
1
FDIC
1
Federal Budget
1
Federal Pilot Programs
1
Federal Procurement Systems
1
Federal Rule 12(b)(6)
1
Federal Rules of Civil Procedure
1
Federal Sentencing Guidelines
1
Fee-Shifting
1
Fees
1
Fiduciary Rule
1
Final Guidance
1
Financial Conduct Authority (FCA)
1
Financial Crisis
1
Financial Instruments
1
Financial Markets
1
Financial Sector
1
FinTech
1
First Amendment
1
Fixing America’s Surface Transportation Act (FAST Act)
1
Flame Retardant
1
Ford Motor
1
Foreign Nationals
1
Foreign Patent Applications
1
Foreign Workers
1
France
1
FRAND
1
Fraud
1
Fresenius
1
Frozen Assets
1
FTC v Actavis
1
Functionality
1
GAAP
1
GATT
1
GDP
1
General Data Protection Regulation (GDPR)
1
Genetic Services
1
Genetically Engineered Animals
1
Genome Project
1
Genzyme
1
Germany
1
Getty Images
1
Global Economy
1
Global Market
1
GM/Synbio Algae Project
1
GMO Bans
1
Grants
1
Green Guides
1
Greenhouse Gas Emissions
1
Grocery Stores
1
Guilty Pleas
1
Hackers
1
Hart-Scott-Rodino Act
1
Harvard University
1
Hazardous Substances
1
Heads of Agreement (HOA)
1
Health Insurance Exchanges
1
Healthcare Costs
1
HIPAA
1
Hitachi
1
HITECH
1
Honeybees
1
Hospira
1
Human Rights
1
Hydrocarbons
1
Incentives
1
Income Taxes
1
Indictments
1
Industrial Design
1
Industry Consolidation
1
Information Disclosure Statement
1
Inherent Disclosure Doctrine
1
Insider Trading
1
Intangible Property
1
Intellectual Property Owners Association
1
InterDigital Communications v ITC
1
Interest Rates
1
Internet of Things
1
Investment
1
Investment Banks
1
Investment Funds
1
IP Assignment Agreements
1
IRB
1
Ireland
1
IRS
1
Italy
1
ITAR
1
ITC
1
Jazz Pharmaceuticals
1
Joint Infringement
1
Joint Venture
1
JPMorgan Chase
1
Judicial Review
1
Kappos
1
Kickbacks
1
L-1 Visas
1
Labeling
1
Landlords
1
Lautenberg Act
1
Leases
1
LEED Certified
1
LEED Rules
1
Leveraged Lending
1
Liability Insurance
1
License Agreements
1
License Fees
1
Life Technologies Corp v Promega Corp
1
Limelight
1
Limelight Networks
1
Litigation Strategies
1
Local Ordinance
1
Local Sourcing
1
Lost Profits
1
Luxembourg
1
Machine-or-Transformation Test
1
Manufacturing Facilities
1
Martin Shkreli
1
Meal and Entertainment Expenditures
1
Media
1
Medical Reimbursement
1
Medicare Part B
1
Medtronic
1
Medtronic v Boston Scientific
1
Member State
1
Memorandum of Guidance
1
Mental Health
1
Menu-Labeling
1
Methane
1
mHealth
1
Microsoft
1
Milestone Payments
1
Mining
1
Misleading Impressions
1
Misleading Statements
1
Mobile Apps
1
Mobile Devices
1
Mortgages
1
Motion for Sanctions
1
Motion To Stay
1
MPEP
1
Multi-Factor Test
1
Municipal Bonds
1
Municipalities
1
Myriad v Ambry
1
NAICS
1
Name and Likeness
1
Nanomaterials
1
Nanomedicine
1
Natural Resources
1
NCAA
1
NEPA
1
Noerr-Pennington Doctrine
1
Non-Compete Agreements
1
Non-Practicing Entities
1
Notice of Intent
1
NPRM
1
NRDC
1
Nunc Pro Tunc
1
O-1 Aliens of Extraordinary Ability
1
OEHHA
1
OFAC
1
Off-Campus Departments
1
Off-Label Use
1
Offshore Companies
1
Olympics
1
Omissions
1
On-Sale Bar
1
ONC
1
Online Drug Sales
1
Open Payments
1
Opioid
1
Orange Book
1
Order to Stay
1
Organic Seed Growers & Trade Assn
1
Orphan Drugs
1
OSHA
1
OTC
1
Outpatient Prospective Payment System (OPPS)
1
Partnerships
1
Patent Cooperation Treaty
1
Patent Expiration
1
Patent Owner Preliminary Response
1
Patent Portfolios
1
Patent Term Extensions
1
Patent-in-Suit
1
Patient Access
1
Patient-Specific
1
Pay-For-Delay
1
PCBs
1
Penalties
1
Performance and Accountability Report
1
Permanent Injunctions
1
Personal Care Products
1
Petitions for Review
1
Pharmacies
1
PHSA
1
Plant Patents
1
Poison Pill
1
Policies and Procedures
1
Political Appointments
1
Political Campaigns
1
Portal
1
Power Plants
1
Premarket Approval Applications
1
Premiums
1
PricewaterhouseCoopers
1
Prior User
1
Prioritized Examination
1
Private Right of Action
1
Proctor & Gamble
1
Product Development Protocols
1
Product Exclusivity
1
Product Hopping
1
Product Packaging
1
Proposed Amendments
1
Provider Payments
1
Provisional Applications
1
PTO
1
Public Domain
1
Public Funds
1
Public Health
1
Public Nuisance
1
Public Policy
1
Public Private Partnerships (P3s)
1
Public Utilities Commission
1
Punitive Damages
1
Qualifying Income
1
R&D
1
RanBaxy
1
Ratification
1
Real Party in Interest
1
Recordkeeping Requirements
1
Recycling
1
Registration
1
Regulatory Agencies
1
Reimbursement Codes
1
REIT
1
Remand
1
Remediation
1
Repeal
1
Reporting Requirements
1
Request for Continued Examination
1
Research Tools
1
Retailers
1
Revenue
1
Reverse Takeovers
1
Right of Publicity
1
Risk Assessment
1
RMBS
1
ROI
1
Roslin
1
Royal Bank of Scotland
1
Rule 10b-5
1
Rulemaking Process
1
S&P
1
SAIC
1
Salmon
1
SALT
1
Sarbanes-Oxley
1
Satire
1
SBA
1
SBIRs
1
Scope of the Claim
1
Scotland
1
Secretary of HHS
1
Section 10(b)
1
Section 11
1
Section 271
1
Section 5
1
Securities
1
Securities Act
1
Securities Litigation
1
Securities Violations
1
Series A
1
Set-Asides
1
Shareholders
1
Sharing Economy
1
Silicon Valley
1
Site-Neutral Exception
1
SMEs
1
SnapChat
1
Solar Energy
1
Source Code
1
SpaceX
1
Spain
1
Special Districts
1
Special Purpose Vehicles
1
Standing
1
State Regulators
1
State-Owned Enterprises
1
Stock Exchange
1
Stock Prices
1
Stocks
1
Storm Water Pollution Prevention Plan
1
Stormwater Discharge Permits
1
Strategic Planning
1
Strict Liability
1
STRONG Patents Act
1
STTR
1
Student Athletes
1
Students
1
Subject Matter Jurisdiction
1
Subprime Mortgages
1
Subsidiaries
1
Supplementary Protection Certificate
1
Supply Chain
1
Surgery
1
Switzerland
1
Takeda Pharmaceuticals
1
Takeover Bids
1
Tariffs
1
Teaching Hospitals
1
Tech Industry
1
Technical Standards
1
Tenants
1
Testimony
1
Textiles
1
The Common Rule
1
The Copyright Act
1
The Enlarged Board of Appeals
1
The Nagoya Protocol
1
The Patent Act
1
Third-Party
1
Tort
1
Tourists
1
Toxic Exposure
1
Trade Relations
1
Trade Restrictions
1
Trade Secrets Protection Act of 2014
1
Trademark Application
1
Trademark Infringement
1
Trademark Registration
1
Trademark Trial and Appeal Board
1
Training
1
Transfer Pricing
1
Transfer Taxes
1
Transfers
1
Transformative Use
1
Transportation Industry
1
Travel Expenses
1
TRIPS Agreement
1
Twombly/Iqbal Pleading Standard
1
Uber
1
Uniform Trade Secrets Acts
1
University of California
1
Urban Planning & Development
1
US Trade Policies
1
USTR
1
Vacated
1
Video Games
1
Visas
1
Volatile Organic Compounds (VOC)
1
WARF
1
Washington Mutual
1
Waste
1
Water
1
Water Pollution
1
Webinar
1
Wind Power
1
WIPO
1
Work Computer
1
Worker Protection Standard
1
Workplace Hazards
1
Written Descriptions
1
Wyeth
1
Yates Memorandum